![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 28494 |
FusionGeneSummary for PPP4C_MVP |
![]() |
Fusion gene information | Fusion gene name: PPP4C_MVP | Fusion gene ID: 28494 | Hgene | Tgene | Gene symbol | PPP4C | MVP | Gene ID | 5531 | 9961 |
Gene name | protein phosphatase 4 catalytic subunit | major vault protein | |
Synonyms | PP-X|PP4|PP4C|PPH3|PPP4|PPX | LRP|VAULT1 | |
Cytomap | 16p11.2 | 16p11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein phosphatase 4 catalytic subunitprotein phosphatase 4 (formerly X), catalytic subunitprotein phosphatase X, catalytic subunit | major vault proteinlung resistance-related proteintesticular secretory protein Li 30 | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | P60510 | Q14764 | |
Ensembl transtripts involved in fusion gene | ENST00000279387, ENST00000561610, | ENST00000357402, ENST00000452209, ENST00000395353, ENST00000566554, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 2 X 2 X 2=8 |
# samples | 1 | 2 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: PPP4C [Title/Abstract] AND MVP [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | MVP | GO:0023057 | negative regulation of signaling | 16441665 |
Tgene | MVP | GO:0031953 | negative regulation of protein autophosphorylation | 16441665 |
Tgene | MVP | GO:0038127 | ERBB signaling pathway | 15133037 |
Tgene | MVP | GO:0061099 | negative regulation of protein tyrosine kinase activity | 16441665 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | TGCT | TCGA-2G-AALY-01A | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000279387 | ENST00000357402 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000279387 | ENST00000452209 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000279387 | ENST00000395353 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000279387 | ENST00000566554 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
In-frame | ENST00000561610 | ENST00000357402 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000561610 | ENST00000452209 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000561610 | ENST00000395353 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
5CDS-intron | ENST00000561610 | ENST00000566554 | PPP4C | chr16 | 30087796 | + | MVP | chr16 | 29855814 | + |
Top |
FusionProtFeatures for PPP4C_MVP |
![]() |
Hgene | Tgene |
PPP4C | MVP |
Protein phosphatase that is involved in many processessuch as microtubule organization at centrosomes, maturation ofspliceosomal snRNPs, apoptosis, DNA repair, tumor necrosis factor(TNF)-alpha signaling, activation of c-Jun N-terminal kinaseMAPK8, regulation of histone acetylation, DNA damage checkpointsignaling, NF-kappa-B activation and cell migration. The PPP4C-PPP4R1 PP4 complex may play a role in dephosphorylation andregulation of HDAC3. The PPP4C-PPP4R2-PPP4R3A PP4 complexspecifically dephosphorylates H2AFX phosphorylated on Ser-140(gamma-H2AFX) generated during DNA replication and required forDNA double strand break repair. Dephosphorylates NDEL1 at CDK1phosphorylation sites and negatively regulates CDK1 activity ininterphase (By similarity). In response to DNA damage, catalyzesRPA2 dephosphorylation, an essential step for DNA repair since itallows the efficient RPA2-mediated recruitment of RAD51 tochromatin. {ECO:0000250, ECO:0000269|PubMed:11698396,ECO:0000269|PubMed:12668731, ECO:0000269|PubMed:12934076,ECO:0000269|PubMed:1336397, ECO:0000269|PubMed:15805470,ECO:0000269|PubMed:18347064, ECO:0000269|PubMed:18487071,ECO:0000269|PubMed:18614045, ECO:0000269|PubMed:18758438,ECO:0000269|PubMed:20154705}. | Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involvedin signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates IFNG-mediated STAT1signaling and subsequent activation of JAK. Down-regulates SRCactivity and signaling through MAP kinases.{ECO:0000269|PubMed:15133037, ECO:0000269|PubMed:16418217,ECO:0000269|PubMed:16441665}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 112_164 | 544 | 894 | Repeat | Note=MVP 3 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 165_217 | 544 | 894 | Repeat | Note=MVP 4 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 218_272 | 544 | 894 | Repeat | Note=MVP 5 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 273_323 | 544 | 894 | Repeat | Note=MVP 6 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 2_56 | 544 | 894 | Repeat | Note=MVP 1 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 324_379 | 544 | 894 | Repeat | Note=MVP 7 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 380_457 | 544 | 894 | Repeat | Note=MVP 8 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 458_520 | 544 | 894 | Repeat | Note=MVP 9 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000357402 | + | 9 | 15 | 57_111 | 544 | 894 | Repeat | Note=MVP 2 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 112_164 | 544 | 894 | Repeat | Note=MVP 3 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 165_217 | 544 | 894 | Repeat | Note=MVP 4 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 218_272 | 544 | 894 | Repeat | Note=MVP 5 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 273_323 | 544 | 894 | Repeat | Note=MVP 6 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 2_56 | 544 | 894 | Repeat | Note=MVP 1 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 324_379 | 544 | 894 | Repeat | Note=MVP 7 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 380_457 | 544 | 894 | Repeat | Note=MVP 8 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 458_520 | 544 | 894 | Repeat | Note=MVP 9 |
Tgene | MVP | chr16:30087796 | chr16:29855814 | ENST00000395353 | + | 9 | 15 | 57_111 | 544 | 894 | Repeat | Note=MVP 2 |
Top |
FusionGeneSequence for PPP4C_MVP |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_PPP4C_ENST00000279387_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_382aa MAEISDLDRQIEQLRRCELIKESEVKALCAKARHFEVNDRKDPQETAKLFSVPDFVGDACKAIASRVRGAVASVTFDDFHKNSARIIRTA VFGFETSEAKGPDGMALPRPRDQAVFPQNGLVVSSVDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQK ILDQSEAEKARKELLELEALSMAVESTGTAKAEAESRAEAARIEGEGSVLQAKLKAQALAIETEAELQRVQKVRELELVYARAQLELEVS KAQQLAEVEVKKFKQMTEAIGPSTIRDLAVAGPEMQVKLLQSLGLKSTLITDGSTPINLFNTAFGLLGMGPEGQPLGRRVASGPSPGEGI >In-frame_PPP4C_ENST00000561610_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_382aa MAEISDLDRQIEQLRRCELIKESEVKALCAKARHFEVNDRKDPQETAKLFSVPDFVGDACKAIASRVRGAVASVTFDDFHKNSARIIRTA VFGFETSEAKGPDGMALPRPRDQAVFPQNGLVVSSVDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQK ILDQSEAEKARKELLELEALSMAVESTGTAKAEAESRAEAARIEGEGSVLQAKLKAQALAIETEAELQRVQKVRELELVYARAQLELEVS KAQQLAEVEVKKFKQMTEAIGPSTIRDLAVAGPEMQVKLLQSLGLKSTLITDGSTPINLFNTAFGLLGMGPEGQPLGRRVASGPSPGEGI |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_PPP4C_ENST00000279387_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_1146nt ATGGCGGAGATCAGCGACCTGGACCGGCAGATCGAGCAGCTGCGTCGCTGCGAGCTCATCAAGGAGAGCGAAGTCAAGGCCCTGTGCGCT AAGGCCAGGCACTTTGAGGTGAATGACCGGAAGGACCCCCAAGAGACGGCCAAGCTCTTTTCAGTGCCAGACTTTGTAGGTGATGCCTGC AAAGCCATCGCATCCCGGGTGCGGGGGGCCGTGGCCTCTGTCACTTTCGATGACTTCCATAAGAACTCAGCCCGCATCATTCGCACTGCT GTCTTTGGCTTTGAGACCTCGGAAGCGAAGGGCCCCGATGGCATGGCCCTGCCCAGGCCCCGGGACCAGGCTGTCTTCCCCCAAAACGGG CTGGTGGTCAGCAGTGTGGACGTGCAGTCAGTGGAGCCTGTGGATCAGAGGACCCGGGACGCCCTGCAACGCAGCGTCCAGCTGGCCATC GAGATCACCACCAACTCCCAGGAAGCGGCGGCCAAGCATGAGGCTCAGAGACTGGAGCAGGAAGCCCGCGGCCGGCTTGAGCGGCAGAAG ATCCTGGACCAGTCAGAAGCCGAGAAAGCTCGCAAGGAACTTTTGGAGCTGGAGGCTCTGAGCATGGCCGTGGAGAGCACCGGGACTGCC AAGGCGGAGGCCGAGTCCCGTGCGGAGGCAGCCCGGATTGAGGGAGAAGGGTCCGTGCTGCAGGCCAAGCTAAAAGCACAGGCCTTGGCC ATTGAAACGGAGGCTGAGCTCCAGAGGGTCCAGAAGGTCCGAGAGCTGGAACTGGTCTATGCCCGGGCCCAGCTGGAGCTGGAGGTGAGC AAGGCTCAGCAGCTGGCTGAGGTGGAGGTGAAGAAGTTCAAGCAGATGACAGAGGCCATAGGCCCCAGCACCATCAGGGACCTTGCTGTG GCTGGGCCTGAGATGCAGGTAAAACTGCTCCAGTCCCTGGGCCTGAAATCAACCCTCATCACCGATGGCTCCACTCCCATCAACCTCTTC AACACAGCCTTTGGGCTGCTGGGGATGGGGCCCGAGGGTCAGCCCCTGGGCAGAAGGGTGGCCAGTGGGCCCAGCCCTGGGGAGGGGATA >In-frame_PPP4C_ENST00000561610_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_1146nt ATGGCGGAGATCAGCGACCTGGACCGGCAGATCGAGCAGCTGCGTCGCTGCGAGCTCATCAAGGAGAGCGAAGTCAAGGCCCTGTGCGCT AAGGCCAGGCACTTTGAGGTGAATGACCGGAAGGACCCCCAAGAGACGGCCAAGCTCTTTTCAGTGCCAGACTTTGTAGGTGATGCCTGC AAAGCCATCGCATCCCGGGTGCGGGGGGCCGTGGCCTCTGTCACTTTCGATGACTTCCATAAGAACTCAGCCCGCATCATTCGCACTGCT GTCTTTGGCTTTGAGACCTCGGAAGCGAAGGGCCCCGATGGCATGGCCCTGCCCAGGCCCCGGGACCAGGCTGTCTTCCCCCAAAACGGG CTGGTGGTCAGCAGTGTGGACGTGCAGTCAGTGGAGCCTGTGGATCAGAGGACCCGGGACGCCCTGCAACGCAGCGTCCAGCTGGCCATC GAGATCACCACCAACTCCCAGGAAGCGGCGGCCAAGCATGAGGCTCAGAGACTGGAGCAGGAAGCCCGCGGCCGGCTTGAGCGGCAGAAG ATCCTGGACCAGTCAGAAGCCGAGAAAGCTCGCAAGGAACTTTTGGAGCTGGAGGCTCTGAGCATGGCCGTGGAGAGCACCGGGACTGCC AAGGCGGAGGCCGAGTCCCGTGCGGAGGCAGCCCGGATTGAGGGAGAAGGGTCCGTGCTGCAGGCCAAGCTAAAAGCACAGGCCTTGGCC ATTGAAACGGAGGCTGAGCTCCAGAGGGTCCAGAAGGTCCGAGAGCTGGAACTGGTCTATGCCCGGGCCCAGCTGGAGCTGGAGGTGAGC AAGGCTCAGCAGCTGGCTGAGGTGGAGGTGAAGAAGTTCAAGCAGATGACAGAGGCCATAGGCCCCAGCACCATCAGGGACCTTGCTGTG GCTGGGCCTGAGATGCAGGTAAAACTGCTCCAGTCCCTGGGCCTGAAATCAACCCTCATCACCGATGGCTCCACTCCCATCAACCTCTTC AACACAGCCTTTGGGCTGCTGGGGATGGGGCCCGAGGGTCAGCCCCTGGGCAGAAGGGTGGCCAGTGGGCCCAGCCCTGGGGAGGGGATA |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_PPP4C_ENST00000279387_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_1359nt CGGGGCCGGAAGTAGGAGCGGCGGCGGCGGCGGCGGCGGCGGTCGAAAGCGGAGTGAAAGAGGGAGGCAGGGAGCCGGAGAGCCGGAACC GGAGTCGCAGCGGCGGAGACCCCTGTGCGGTGCGGAGGGGGCGGCGGCCCCGACTCTGACCCGCGCCGGGGGTGGGCCATGGCGGAGATC AGCGACCTGGACCGGCAGATCGAGCAGCTGCGTCGCTGCGAGCTCATCAAGGAGAGCGAAGTCAAGGCCCTGTGCGCTAAGGCCAGGCAC TTTGAGGTGAATGACCGGAAGGACCCCCAAGAGACGGCCAAGCTCTTTTCAGTGCCAGACTTTGTAGGTGATGCCTGCAAAGCCATCGCA TCCCGGGTGCGGGGGGCCGTGGCCTCTGTCACTTTCGATGACTTCCATAAGAACTCAGCCCGCATCATTCGCACTGCTGTCTTTGGCTTT GAGACCTCGGAAGCGAAGGGCCCCGATGGCATGGCCCTGCCCAGGCCCCGGGACCAGGCTGTCTTCCCCCAAAACGGGCTGGTGGTCAGC AGTGTGGACGTGCAGTCAGTGGAGCCTGTGGATCAGAGGACCCGGGACGCCCTGCAACGCAGCGTCCAGCTGGCCATCGAGATCACCACC AACTCCCAGGAAGCGGCGGCCAAGCATGAGGCTCAGAGACTGGAGCAGGAAGCCCGCGGCCGGCTTGAGCGGCAGAAGATCCTGGACCAG TCAGAAGCCGAGAAAGCTCGCAAGGAACTTTTGGAGCTGGAGGCTCTGAGCATGGCCGTGGAGAGCACCGGGACTGCCAAGGCGGAGGCC GAGTCCCGTGCGGAGGCAGCCCGGATTGAGGGAGAAGGGTCCGTGCTGCAGGCCAAGCTAAAAGCACAGGCCTTGGCCATTGAAACGGAG GCTGAGCTCCAGAGGGTCCAGAAGGTCCGAGAGCTGGAACTGGTCTATGCCCGGGCCCAGCTGGAGCTGGAGGTGAGCAAGGCTCAGCAG CTGGCTGAGGTGGAGGTGAAGAAGTTCAAGCAGATGACAGAGGCCATAGGCCCCAGCACCATCAGGGACCTTGCTGTGGCTGGGCCTGAG ATGCAGGTAAAACTGCTCCAGTCCCTGGGCCTGAAATCAACCCTCATCACCGATGGCTCCACTCCCATCAACCTCTTCAACACAGCCTTT GGGCTGCTGGGGATGGGGCCCGAGGGTCAGCCCCTGGGCAGAAGGGTGGCCAGTGGGCCCAGCCCTGGGGAGGGGATATCCCCCCAGTCT GCTCAGGCCCCTCAAGCTCCTGGAGACAACCACGTGGTGCCTGTACTGCGCTAACTCCTGATTAATACAATGGAAGTTTCTGGGCATTTA >In-frame_PPP4C_ENST00000561610_chr16_30087796_+_MVP_ENST00000357402_chr16_29855814_+_1344nt GTGGGGGAGCCGGGCCGGCTCTAGAATCGAGTTGTCCGCTCCGAGCCCCGGACGGACACTGATCCGCGGGCTCGTCTTGGCCTTTCCCAG GAGACCCCTGTGCGGTGCGGAGGGGGCGGCGGCCCCGACTCTGACCCGCGCCGGGGGTGGGCCATGGCGGAGATCAGCGACCTGGACCGG CAGATCGAGCAGCTGCGTCGCTGCGAGCTCATCAAGGAGAGCGAAGTCAAGGCCCTGTGCGCTAAGGCCAGGCACTTTGAGGTGAATGAC CGGAAGGACCCCCAAGAGACGGCCAAGCTCTTTTCAGTGCCAGACTTTGTAGGTGATGCCTGCAAAGCCATCGCATCCCGGGTGCGGGGG GCCGTGGCCTCTGTCACTTTCGATGACTTCCATAAGAACTCAGCCCGCATCATTCGCACTGCTGTCTTTGGCTTTGAGACCTCGGAAGCG AAGGGCCCCGATGGCATGGCCCTGCCCAGGCCCCGGGACCAGGCTGTCTTCCCCCAAAACGGGCTGGTGGTCAGCAGTGTGGACGTGCAG TCAGTGGAGCCTGTGGATCAGAGGACCCGGGACGCCCTGCAACGCAGCGTCCAGCTGGCCATCGAGATCACCACCAACTCCCAGGAAGCG GCGGCCAAGCATGAGGCTCAGAGACTGGAGCAGGAAGCCCGCGGCCGGCTTGAGCGGCAGAAGATCCTGGACCAGTCAGAAGCCGAGAAA GCTCGCAAGGAACTTTTGGAGCTGGAGGCTCTGAGCATGGCCGTGGAGAGCACCGGGACTGCCAAGGCGGAGGCCGAGTCCCGTGCGGAG GCAGCCCGGATTGAGGGAGAAGGGTCCGTGCTGCAGGCCAAGCTAAAAGCACAGGCCTTGGCCATTGAAACGGAGGCTGAGCTCCAGAGG GTCCAGAAGGTCCGAGAGCTGGAACTGGTCTATGCCCGGGCCCAGCTGGAGCTGGAGGTGAGCAAGGCTCAGCAGCTGGCTGAGGTGGAG GTGAAGAAGTTCAAGCAGATGACAGAGGCCATAGGCCCCAGCACCATCAGGGACCTTGCTGTGGCTGGGCCTGAGATGCAGGTAAAACTG CTCCAGTCCCTGGGCCTGAAATCAACCCTCATCACCGATGGCTCCACTCCCATCAACCTCTTCAACACAGCCTTTGGGCTGCTGGGGATG GGGCCCGAGGGTCAGCCCCTGGGCAGAAGGGTGGCCAGTGGGCCCAGCCCTGGGGAGGGGATATCCCCCCAGTCTGCTCAGGCCCCTCAA |
Top |
FusionGenePPI for PPP4C_MVP |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
PPP4C | REL, SMEK1, TIPRL, SMEK2, PPP4R1, PPP2R1A, PPP2CB, PPP4R2, CCDC6, BAG6, GEMIN4, SMN1, DHX38, CCT2, TCP1, CCT5, CCT3, CCT6A, CCT4, IGBP1, CCT7, PPP4R4, PPP2R5D, CCT8, RELA, TP53, JUN, NFKB1, TRAF6, TLR4, MAP4K1, SRRM2, HDAC3, PPP2R2B, PPP2R2D, PPP2R4, GLYATL3, PLOD3, CCT6P1, WDR81, SLC25A31, TRMT1L, ATAD3A, EEF1A1, PPME1, ATAD3B, TUBA3C, TK1, ELAVL1, TRIM28, CUL3, CAND1, IKBKG, LCMT1, DYNLT1, XPO1, PPP2CA, UBXN10, BCAS2, CDC5L, CLASP2, PPP2R2A, PRPF19, SUPT5H, RNGTT | MVP | PARP4, ESR1, PTEN, SIRT7, SLC2A4, RFWD2, TEP1, DHX9, CHMP4B, NNT, EPHX2, HP, KPNA2, CYTB, PLSCR1, GIT2, MVP, CKAP4, POT1, BAG3, HSP90AB1, NCBP1, VAT1, PSAP, BZRAP1, DISC1, DLX2, ADAMTSL4, AES, BANP, C1orf94, CALCOCO2, CAMK2B, CCDC36, FAM154A, FAM46C, GOLGA2, KCTD9, KPNA3, MDFI, MEOX1, MEOX2, MID2, MKL1, NOTCH2NL, OBFC1, PIH1D2, PSTPIP1, RAB3IP, RBPMS, REL, RHOXF2, RIMBP3, RNF111, SERTAD1, SKIL, TCF4, TFCP2, TP53, TRAF2, TRIM27, TRIM42, TRIP13, TRIP6, VAC14, ZBTB32, ZMIZ2, DDX19B, KRAS, CLTC, LGALS3BP, PTPN1, STAT5B, TGM2, GTSE1, SKI, MCM2, NF2, SNW1, CDC5L, U2AF2, GOPC, RCOR3, HSPA8, UBC, CYLD, BRCA1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PPP4C_MVP |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PPP4C_MVP |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | MVP | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | MVP | C0029408 | Degenerative polyarthritis | 1 | CTD_human |